Researchers around the world are racing to patent the SARS virus and its genetic material, rekindling criticism of laws that allow people to claim intellectual property rights on living things. Nonprofit and government agencies say their applications are intended to keep the SARS work in the public domain, while private companies contend patents will protect their research and development, and possibly lead to drug royalties.
May 07, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The Global Leaders in Consulting awards are for those who are making a big impression within the industry, but also worldwide.
Aimed to help Insurers prevent, prepare and prevail In adjudicating complex claims, negotiating settlements and winning cases.
Women, Influence & Power in Law UK Awards honors women lawyers who have made a remarkable difference in the legal profession.
The New York office of Epstein Becker & Green is seeking an attorney to work at the level of a mid-level or senior associate to join its...
The Los Angeles office of Epstein Becker & Green is seeking an attorney to work at the level of a mid-level associate in its growing nat...
The Newark office of Epstein Becker & Green is seeking an attorney to work at the level of a mid-level or senior associate in its growin...
Pond Lehocky Giordano LLP would like to congratulate Jerry Lehocky and his team on PA's largest workers' compensation settlement.